comparemela.com

Latest Breaking News On - Xiaolan zhou - Page 1 : comparemela.com

Chinese biopharmaceutical firm Jixing bags $162m Series D round

Jixing Pharmaceutical has pocketed a combined $162 million from Germany's Bayer and New York-based investment firm RTW Investments.

Xiaolan zhouBayer agBayer pharmaceuticals chinaJixing pharmaceuticalNew york based

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

United statesJi xingNew yorkBroderick wongXiaolan zhouImke meyerJuergen eckhardtBayer agJi xing pharmaceuticalsPharmaceuticals divisionHead of business developmentBayer pharmaceuticals chinaJi xing pharmaceuticals limitedNew york cityExecutive vice presidentBayer greater china

Bayer and RTW Investments lead Series D financing in Chinese biotech Ji Xing Pharmaceuticals

Germany - Bayer and RTW Investments, LP today announced an equity investment into Ji Xing Pharmaceuticals Limited in the amount of USD 35 million and USD 127 million respectively. JIXING, founded.

Ji xingBroderick wongJosh baldwinImke meyerXiaolan zhouJuergen eckhardtBayer pharmaceuticals chinaHead of business developmentBayer agPharmaceuticals divisionJi xing pharmaceuticals limitedXing pharmaceuticals limitedExecutive vice presidentBayer greater chinaExecutive committeeBusiness development

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

Li chenXiaolan zhouBayer pharmaceuticals chinaBayer agOffice of the state councilHua medicine the companyChina national medical products administrationYear national health planningPharmaceuticals divisionNational medical products administrationInternational diabetes federationPharmaceuticals china innovation centerInnovative first in class glucokinase activatorHuatangning is approvedNew typeTreatment paradigm

Chinese company sees approval for diabetes drug

Hua Medicine says its new drug application for HuaTangNing has been approved by the National Medical Products Administration in China.

Li chenXiaolan zhouBayer pharmaceuticals chinaBayer agNational medical products administrationInternational diabetes federationHua medicineLancet diabetesNature medicineHealthy china

vimarsana © 2020. All Rights Reserved.